Gujarat Themis Biosyn Limited - Cash Flow Statement (TTM)

Gujarat Themis Biosyn Limited
IN ˙ NSEI
₹ 383.80 ↑2.10 (0.55%)
2025-09-05
SHARE PRICE
Cash Flow Statement (TTM)

Gujarat Themis Biosyn Limited Cash Flow Statement shows changes in cash positions over time. Cash Flow Statement data includes Cash from Operating Activities (CFOP), Cash from Investing Activities, and Cash from Financing Activities.

All numbers are times 1,000,000 except per share units.

2020
09-30
2021
03-31
2021
09-30
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
Cash From Operating Activities 97 105 288 403 302 395 575 642 888 910
Change (%) 8.19 173.66 39.88 -25.09 30.80 45.53 11.70 38.25 2.54
% of Cash Flow 577.73 338.07 1,844.67 -1,147.31 -749.25 681.74 4,598.87 15,499.18 1,397.06 1,742.27
Cash From Investing Activities -15 -23 -227 -298 -184 -204 -468 -552 -745 -1,118
Change (%) 47.13 908.93 31.33 -38.44 11.13 129.20 18.04 34.87 50.16
% of Cash Flow -90.82 -72.28 -1,454.01 849.01 455.61 -352.21 -3,741.94 -13,326.55 -1,171.84 -2,140.18
Cash From Financing Activities -65 -52 -45 -140 -159 -133 -95 -86 -80 260
Change (%) -20.78 -12.07 208.18 13.37 -16.18 -28.86 -9.24 -7.33 -426.92
% of Cash Flow -386.90 -165.79 -290.67 398.30 393.64 -229.53 -756.92 -2,072.63 -125.22 497.91
Cash Flow 17 31 16 -35 -40 58 12 4 64 52
Change (%) 84.88 -49.85 -324.91 14.71 -243.75 -78.43 -66.86 1,433.82 -17.78
% of Cash Flow 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00

Source: Capital IQ

Other Listings
IN:506879
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista